The WHO score predicts treatment outcome in low risk gestational trophoblastic neoplasia patients treated with weekly intramuscular methotrexate

Journal of Cancer Research and Therapeutics

Volumn 9, Issue 1, 2013, Pages 38-43

  Gilani, Mitra M ^a   Fariba, Behnamfar ^a,b   Behtash, Nadereh ^a   Ghaemmaghami, Fatemeh ^a   Moosavi, Azam Sadat ^a   Rezayof, Elahe ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Shahid Beheshti Hospital   (Iran)

Author keywords

Gestational trophoblastic neoplasia; Methotrexate; Mole hydatiform

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; CYCLOPHOSPHAMIDE; DACTINOMYCIN; ETOPOSIDE; LIVER ENZYME; METHOTREXATE; VINCRISTINE;

ADULT; ALOPECIA; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER REGRESSION; CANCER RISK; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; HYSTERECTOMY; INJECTION SITE SKIN NECROSIS; LIVER ENZYME BLOOD LEVEL; LIVER TOXICITY; LOW RISK GESTATIONAL TROPHOBLASTIC NEOPLASIA; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NEUTROPENIA; PATHOPHYSIOLOGY; PATIENT MONITOR; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; RISK FACTOR; SCORING SYSTEM; SIDE EFFECT; STOMATITIS; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; TROPHOBLASTIC TUMOR; WHO SCORE;

ADOLESCENT; ADULT; ANTIMETABOLITES, ANTINEOPLASTIC; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DRUG RESISTANCE, NEOPLASM; FEMALE; GESTATIONAL TROPHOBLASTIC DISEASE; HUMANS; INJECTIONS, INTRAMUSCULAR; METHOTREXATE; MIDDLE AGED; PREGNANCY; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84877273867     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.110357     Document Type: Article

References (21)

1. Berkowitz RS, Goldstein DP Current management of gestational trophoblastic diseases. Gynecol Oncol 2009; 112: 654-62.
2. Soper JT, Mutch DG, Schink JC; American College of Obstetricians and Gynecologists. Diagnosis and treatment of gestational trophoblastic disease: ACOG Practice Bulletin No. 53. Gynecol Oncol 2004; 93: 575-85. (Pubitemid 38766038)
3. Li MC, Hertz R, Spencer DB Effect of Methotrexate therapy upon choriocarcinoma and chorioadenoma. Proc Soc Exp Biol Med 1956; 93: 361-6.
4. Abrão R.A., de Andrade JM, Tiezzi DG, Marana HR, Candido dos Reis FJ, Clagnan WS. Treatment for low-risk gestational trophoblastic disease: Comparison of single-agent methotrexate, dactinomycin and combination regimens. Gynecol Oncol 2008; 108: 149-53.
5. Soper JT, Clarke-Pearson DL, Berchuck A., Rodriguez G, Hammond CB -5-day methotrexate for women with metastatic gestational trophoblastic disease. Gynecol Oncol 1994; 54: 76-9. (Pubitemid 24239412)
6. Matsui H, Suzuka K, Yamazawa K., Tanaka N, Mitsuhashi A, Seki K., et al Relapse rate of patients with low-risk gestational trophoblastic tumor initially treated with single-agent chemotherapy. Gynecol Oncol 2005; 96: 616-20. (Pubitemid 40255478)
7. Kang WD, Choi HS, Kim SM Weekly methotrexate (50mg/m(2)) without dose escalation as a primary regimen for low-risk gestational trophoblastic neoplasia. Gynecol Oncol 2010; 117: 477-8.
8. Kwon JS, Elit L, Mazurka J., Moens F, Schmuck ML Weekly intravenous methotrexate with folinic acid for nonmetastatic gestational trophoblastic neoplasia. Gynecol Oncol 2001; 82: 367-70. (Pubitemid 32730620)
9. Cancer Therapy Evaluation Program Common Terminology Criteria for Adverse Events(CTCAE), Version 3.0,DCTD, NCI, NIH, DHHS. Avaible from: http://www.ctep.cancer.gov. [Last accessed on 2003 Mar 31].
10. McNeish IA, Strickland S, Holden L., Rustin GJ, Foskett M, Seckl MJ, et al Low-risk persistent gestational trophoblastic disease: Outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000. J Clin Oncol 2002; 20: 1838-44. (Pubitemid 34273274)
11. Osborne R, Gerulath A. What is the best regimen for low-risk gestational trophoblastic neoplasia? A review. J Reprod Med 2004; 49: 602-16. (Pubitemid 39128774)
12. Foulmann K, Guastalla JP, Caminet N, Trillet-Lenoir V, Raudrant D., Golfier F, et al What is the best protocol of single-agent methotrexate chemotherapy in nonmetastatic or low-risk metastatic gestational trophoblastic tumors? A review of the evidence. Gynecol Oncol 2006; 102: 103-10. (Pubitemid 43870235)
13. Homesley HD, Blessing JA, Rettenmaier M, Capizzi R.L., Major FJ, Twiggs LB Weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease. Obstet Gynecol 1988; 72: 413-8.
14. Homesley HD, Blessing JA, Schlaerth J, Rettenmaier M., Major FJ Rapid escalation of weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease: A Gynecologic Oncology Group study. Gynecol Oncol 1990; 39: 305-8.
15. Hoffman MS, Fiorica JV, Gleeson N.C., Roberts WS, Cavanagh D. A single institution experience with weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease. Gynecol Oncol 1996; 60: 292-4. (Pubitemid 26058776)
16. Gleeson NC, Finan MA, Fiorica J.V., Robert WS, Hoffman MS, Wilson J. Nonmetastatic gestational trophoblastic disease. Weekly methotrexate compared with 8-day methotrexate-folinic acid. Eur J Gynaecol Oncol 1993; 14: 461-5. (Pubitemid 24056720)
17. Yarandi F, Eftekhar Z, Shojaei H., Kanani S, Sharif A, Hanjani P. Pulse methotrexate versus pulse actinomycin D in the treatment of low-risk gestational trophoblastic neoplasia. Int J Gynaecol Obstet 2008; 103: 33-7.
18. Gilani MM, Yarandi F, Eftekhar Z., Hanjani P. Comparison of pulse methotrexate and pulse dactinomycin in the treatment of low-risk gestational trophoblastic neoplasia. Aust N Z J Obstet Gynaecol 2005; 45: 161-4. (Pubitemid 40528565)
19. Mohit M, Sarraf Z, Sheikhi G., Robati M, Vasheghani-Farahani A. Weekly intramuscular methotrexate in the treatment of low-risk gestational trophoblastic neoplasia. Arch Gynecol Obstet 2009; 280: 775-80.
20. Osborne RJ, Filiaci V, Schink J.C., Mannel RS, Secord AA, Kelley JL, et al Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: A gynecologic oncology group study. J Clin Oncol 2011; 29: 825-31.
21. May T, Goldstein DP, Berkowitz RS Current chemotherapeutic management of patients with gestational trophoblastic neoplasia. Chemother Res Pract 2011; 2011: 806256.